Evidence map›Paper›PMID 41143332›Full record

ArticleDevelopment (Cambridge, England)2025

Broad H3K4me3 domains support oocyte genome silencing and maturation but are dispensable for repression in early embryos.

Trine Skuland, Madeleine Fosslie, Sherif Khodeer, Endalkachew Ashenafi Alemu, Jens Vilstrup Johansen, Marie Indahl, Blanca Corral Castroviejo, Yanjiao Li, Mads Lerdrup, John Arne Dahl and 2 more

Abstract read
In one paragraph

Article in Development (Cambridge, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Trine SkulandDepartment of Reproductive Medicine, Women's Clinic, Oslo University Hospital, 0855 Oslo, Norway.ORCID 0000-0001-9618-5123
Madeleine FosslieCRESCO - Centre for Embryology and Healthy Development, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0373 Oslo, Norway.ORCID 0000-0002-2902-4394
Sherif KhodeerDepartment of Microbiology, Division of Laboratory Medicine, Oslo University Hospital, 0373 Oslo, Norway.
Endalkachew Ashenafi AlemuDepartment of Microbiology, Division of Laboratory Medicine, Oslo University Hospital, 0373 Oslo, Norway.
Jens Vilstrup JohansenBiotech Research & Innovation Centre (BRIC), University of Copenhagen, 2200 Copenhagen, Denmark.
Marie IndahlDepartment of Reproductive Medicine, Women's Clinic, Oslo University Hospital, 0855 Oslo, Norway.
Blanca Corral CastroviejoDepartment of Reproductive Medicine, Women's Clinic, Oslo University Hospital, 0855 Oslo, Norway.
Yanjiao LiCRESCO - Centre for Embryology and Healthy Development, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0373 Oslo, Norway.
Mads LerdrupCRESCO - Centre for Embryology and Healthy Development, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0373 Oslo, Norway.
John Arne DahlCRESCO - Centre for Embryology and Healthy Development, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0373 Oslo, Norway.
Peter Zoltan FedorcsakDepartment of Reproductive Medicine, Women's Clinic, Oslo University Hospital, 0855 Oslo, Norway.
Gareth D GreggainsDepartment of Reproductive Medicine, Women's Clinic, Oslo University Hospital, 0855 Oslo, Norway.ORCID 0000-0003-2424-4694

Funding

Danmarks Grundforskningsfond DNRF115Livsvitenskap, Universitetet i OsloUniversity of Oslo
6 · The paper itself

Abstract

Epigenetic reprogramming and embryonic genome activation (EGA) are crucial events during early development. Establishment of distinctive broad histone H3 lysine 4 trimethylation (H3K4me3) domains in the oocyte is necessary for genome silencing, and their removal in the 2-cell embryo is crucial for EGA and development in mice. However, the stage-specific requirement for broad H3K4me3 domains is unclear. Here, we show that inducing broad H3K4me3 removal in mouse oocytes can relieve genome silencing, impair oocyte maturation timing, and may cause transcriptional reactivation in resulting parthenogenetic 1-cell embryos. We further demonstrate that broad H3K4me3 demethylation precedes EGA but, surprisingly, premature depletion in zygotes or early 2-cell embryos does not alter the transcriptional program. Our findings suggest that broad H3K4me3 domains are required for oocyte genome silencing, timely maturation and post-fertilisation silencing, but onward pre-EGA transcriptional repression is not dependent on the original mark. This work contributes to the understanding of events and mechanisms involved in genome silencing and activation in early development, providing insight into potential modes of failure that may contribute to infertility.

Indexed as

Embryo, MammalianGene SilencingGenomeHistonesOocytesAnimalsEmbryonic DevelopmentEpigenesis, GeneticFemaleGene Expression Regulation, DevelopmentalMethylationMiceZygotehistone H3 trimethyl Lys4HistonesActivationEmbryoH3K4me3KDM5BOocyteSilencing

Identifiers

PMID41143332
PMCPMC12633791

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.